Vancomycin

• Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol Pending
  2024-516232-10-00 Phase IV 1 country Centre Hospitalier Universitaire De Nimes
• Phase IV, randomized, open label, parallel groups clinical trial for evaluating the early Stop of antibiotic Treatment in high-risk febrile … Pending
  2025-524264-38-00 Phase IV 1 country Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
• A medical research to evaluate if MaaT013 is safe and helps children and adolescent with GI-aGvHD after failed two prior therapies. Pending
  2025-524302-15-00 Phase II 4 countries MaaT PHARMA
• EPISSOC : Randomized controlled trial comparing an Early Pleural Irrigation strategy with Saline to the Standard of Care for the management … Pending
  2025-524697-42-00 Phase III 1 country Centre Hospitalier Universitaire Amiens Picardie
• Fecal microbiota transfer for the secondary prevention of recurrent urinary tract infections in premenopausal women: a phase II trial (FEMIT… Recruiting
  2025-520452-28-00 Phase II 1 country Goethe University Frankfurt
• Efficacy and Safety of Vedolizumab Intravenous in Pediatric Chronic Pouchitis Recruiting
  2023-504773-20-00 Phase III 8 countries Takeda Development Center Americas Inc.
• Fecal Microbiota Transplantation to RESCUE patients with unresectable Hcc progressors to first line therapy with AtezolizUmaB and Bevacizuma… Recruiting
  2023-510504-45-00 Phase II 1 country Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura…
• A Randomized controlled open-label phase II trial assessing the efficacy and safety of two-dosing regimens of frozen encapsulated fecal micr… Recruiting
  2024-519748-34-00 Phase II 1 country Goethe University Frankfurt
• Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Recruiting
  2024-513330-38-00 Phase II 1 country Assistance Publique Hopitaux De Paris
• The DALBA-study Introduction of the antibiotic dalbavancin in orthopaedic surgery – an evaluation of: • Health economic costs • Patient-repo… Recruiting
  2025-522088-13-00 Phase IV 1 country Region Midtjylland
• Prospective Randomized Evaluation of Emerging Novel Treatments for Infection prophylaxis in Total Joint Replacement (PREVENT-iT) Recruiting
  2024-515055-38-00 Phase III 1 country Hamilton Health Sciences Corporation
• Influence of antibiotic treatment on the normal flora and the presence of resistance genes in known carriers of ESBL and VRE Recruiting
  2024-517434-17-01 Phase IV 1 country Region Uppsala
• Linezolid or vancomycin surgical site infection prophylaxis LOVip Recruiting
  2023-504986-22-00 Phase III 1 country Assistance Publique Hopitaux De Marseille
• Local Antibiotics for Women Undergoing Breast Reconstruction Surgery with Implants Recruiting
  2024-517672-38-00 Phase III 1 country Rigshospitalet
• Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting
  2023-508442-18-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• Evaluation of EXL01 a new Live Biotherapeutic Product to prevent recurrence of Clostridioides difficile infection in high-risk patients. LIV… Recruiting
  2023-506232-32-00 Phase I/II 1 country Hospices Civils De Lyon
• SAVE- oral antibiotics for treatment of vertebral osteomyelitis Recruiting
  2023-507617-96-01 Phase IV 1 country Rigshospitalet
• Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting
  2023-503582-35-00 Phase IV 4 countries University Medical Center Utrecht
• Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterre… Recruiting
  2024-514952-34-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• Clinical study in adults and young patients with Primary Sclerosing Cholangitis treated with oral vancomycin or placebo Recruiting
  2023-507425-42-00 Phase II 1 country University Of Milano Bicocca
• A Study of Aztreonam-Avibactam (ATM-AVI) Compared to Best Available Therapy in Pediatric Participants with Serious Gram-Negative Bacterial C… Recruiting
  2022-501575-12-00 Phase II 4 countries Pfizer Inc.
• VANCALLO - Prevention of C. difficile infections by oral vancomycin in patients treated for allogeneic hematopoietic stem cell transplantati… Recruiting
  2024-513490-45-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• Antibiotic Impregnated Bone Graft to reduce infection in hip replacement - the ABOGRAFT trial Recruiting
  2024-510921-25-00 Phase II 1 country Region Oestergoetland
• Accelerated treatment of infectious endocarditis Recruiting
  2023-507652-76-00 Phase III/IV 1 country Region Skane

Showing 1–24 of 30 trials